| P50 | author | Mary K Kuhner | Q55816146 |
| | Rumen Kostadinov | Q82105461 |
| | Patricia L Blount | Q87993069 |
| | Robert D Odze | Q87995042 |
| | Carissa A. Sanchez | Q116977284 |
| P2093 | author name string | Carlo C Maley | |
| | Xiaohong Li | |
| | Cassandra L Sather | |
| | Brian J Reid | |
| | Patricia C Galipeau | |
| | Thomas L Vaughan | |
| | Amitabh Srivastava | |
| | Thomas G Paulson | |
| P2860 | cites work | The significance of unstable chromosomes in colorectal cancer. | Q53376250 |
| | Progression to cancer in Barrett's esophagus is associated with genomic instability | Q69937048 |
| | An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus | Q70767753 |
| | Methods for the determination of epithelial cell kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens | Q71249338 |
| | Deletion at fragile sites is a common and early event in Barrett's esophagus. | Q35002032 |
| | New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management | Q35057339 |
| | Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells | Q35476763 |
| | Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis | Q36370513 |
| | Comparative lesion sequencing provides insights into tumor evolution | Q36670136 |
| | Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis | Q37135288 |
| | Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma | Q37198249 |
| | Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm | Q39386631 |
| | Controlled mechanical distension of the human oesophagus: sensory and biomechanical findings | Q40603235 |
| | Genetic variegation of clonal architecture and propagating cells in leukaemia | Q44426152 |
| | Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. | Q50904831 |
| | NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma | Q21563424 |
| | Cancer as an evolutionary and ecological process | Q22122026 |
| | Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 |
| | A map of human genome variation from population-scale sequencing | Q24617794 |
| | Neutral evolution of mutational robustness | Q24655790 |
| | BEAST: Bayesian evolutionary analysis by sampling trees | Q27860723 |
| | Evolutionary trees from DNA sequences: A maximum likelihood approach | Q27860898 |
| | Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 |
| | Genetic instabilities in human cancers | Q28131826 |
| | Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis | Q28194560 |
| | The clonal evolution of tumor cell populations | Q28271546 |
| | Tumour evolution inferred by single-cell sequencing | Q28646966 |
| | Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data | Q28768988 |
| | A new multipoint method for genome-wide association studies by imputation of genotypes | Q29547209 |
| | The landscape of somatic copy-number alteration across human cancers | Q29547648 |
| | Clonal evolution in cancer | Q29547696 |
| | Analysis of array CGH data: from signal ratio to gain and loss of DNA regions | Q30961366 |
| | A fast and flexible method for the segmentation of aCGH data | Q31170382 |
| | apTreeshape: statistical analysis of phylogenetic tree shape | Q33228311 |
| | Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus | Q33321476 |
| | Smoothness within ruggedness: the role of neutrality in adaptation. | Q33625679 |
| | Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials | Q33767211 |
| | History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus | Q33786336 |
| | Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view | Q33842160 |
| | Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression | Q33902184 |
| | Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data | Q33951424 |
| | Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 |
| | Punctuated equilibrium comes of age. | Q34344229 |
| | Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study | Q34471919 |
| | Meta analysis: Cancer risk in Barrett's oesophagus. | Q34694561 |
| | Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing | Q34812680 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | Barrett's esophagus | Q808892 |
| P304 | page(s) | e1003553 | |
| P577 | publication date | 2013-06-13 | |
| P1433 | published in | PLOS Genetics | Q1893441 |
| P1476 | title | NSAIDs modulate clonal evolution in Barrett's esophagus | |
| P478 | volume | 9 | |